Clinical Trials in Minneapolis

Showing 6521-6540 of 14,456 trials

Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa

NCT04220112

The goal of the purposed research is to extend prior work (STUDY00003758: Real-time fMRI Neurofeedback to Alter Limbic Disturbances in Anorexia Nervosa) on real-time fMRI (rt-fMRI) neurofeedback (focused on amygdala down-regulation) as an innovative neurocircuitry-targeted intervention for anorexia nervosa (AN). This project will include randomization to rt-fMRI or a sham controlled group to answer the following important unresolved question: Does a patient-led procedure aimed at altering brain activity impact limbic circuit function and key eating disorder and psychiatric symptoms in AN above the effect of a matched, but non-targeted sham condition?

AnorexiaAnorexia Nervosa

University of Minnesota33 participantsStarted Mar 2020

Minneapolis, Minnesota, United States

COMPLETEDPhase 4< 1 mile

Evaluation of Diaphragm Movement After an Interscalene Block

NCT03636542

The purpose of this study is to evaluate the movement of the diaphragm after an interscalene block with liposome bupivacaine (LB) compared to interscalene block (IB) with bupivacaine. This study will evaluate if there is a possible prolonged phrenic nerve paralysis when using liposome bupivacaine in an interscalene block, using ultrasound.

Phrenic Nerve Paralysis

University of Minnesota26 participantsStarted Aug 2018

Minneapolis, Minnesota, United States

COMPLETEDPhase 34.5 miles

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

NCT03208985

This study is designed to assess whether consumers select and use ella® (ulipristal acetate 30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in an OTC-like setting.

Emergency Contraception

HRA Pharma1,270 participantsStarted May 2017

Rancho Cucamonga, California, United States • Boulder, Colorado, United States • Denver, Colorado, United States +31 more locations

Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa

Evaluation of Diaphragm Movement After an Interscalene Block

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Find Trials by Condition in Minneapolis

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

A Clinical Trial of PRAX-114 in Participants With Essential Tremor

Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

Transforming Primary Care for Older Canadians Living With Frailty

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory